UPDATE | July 16, 2020

Asia's First Bioprocessing Research and Training Institute to Open in South Korea

  • MAIL

The South Korean government agencies, the Ministry of Trade, Industry and Energy, and the Ministry of Health and Welfare announced plans to foster Asia's bioprocessing professionals. Dr. Tae Han Kim, CEO of Samsung Biologics attended the signing ceremony to support the agreement with aims to further strengthen and expand Korea's bio-industry 

The South Korean government agencies, the Ministry of Trade, Industry and Energy, and the Ministry of Health and Welfare announced plans to foster Asia's bioprocessing professionals. Dr. Tae Han Kim, CEO of Samsung Biologics attended the signing ceremony to support the agreement with aims to further strengthen and expand Korea's bio-industry. 

 

Under the agreement, the two ministries will build Asia's first state-run bioprocessing research and training institute in Korea. In response to a surge in biomedicine manufacturing in Korea, 60 billion won ($51.3 million) is set to be invested by 2025 to provide advanced training for professionals and resolve imbalances in staffing. This investment is expected to effectively establish Korea as a major biocluster in Asia.  

The South Korean government agencies, the Ministry of Trade, Industry and Energy, and the Ministry of Health and Welfare announced plans to foster Asia's bioprocessing professionals. Dr. Tae Han Kim, CEO of Samsung Biologics attended the signing ceremony to support the agreement with aims to further strengthen and expand Korea's bio-industry 

The South Korean government agencies, the Ministry of Trade, Industry and Energy, and the Ministry of Health and Welfare announced plans to foster Asia's bioprocessing professionals. Dr. Tae Han Kim, CEO of Samsung Biologics attended the signing ceremony to support the agreement with aims to further strengthen and expand Korea's bio-industry. 

 

Under the agreement, the two ministries will build Asia's first state-run bioprocessing research and training institute in Korea. In response to a surge in biomedicine manufacturing in Korea, 60 billion won ($51.3 million) is set to be invested by 2025 to provide advanced training for professionals and resolve imbalances in staffing. This investment is expected to effectively establish Korea as a major biocluster in Asia.

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

  • MAIL
Back to List

SITE MAP

close
Close

Your download is ready

Click Download.

Download
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

COOKIE POLICY

Get focus link
Last Updated: [31 Mar 2023]

This Cookie Policy applies to the Samsung Biologics website (the “Website”). Please read this Cookie Policy carefully and feel free to contact us if you have any questions.

Your Privacy
- What are cookies?

A cookie is a small text file that a website saves on your computer or mobile device when you visit the Website. It enables the Website to remember your actions and preferences (such as language preferences) over a period of time, so you don't have to keep re-entering them whenever you come back to the Website or browse from one page to another.

- How to control cookies

You can control and/or delete cookies as you wish - for details, see http://www.aboutcookies.org. You can delete all cookies that are already on your computer and you can set most browsers to prevent them from being placed. If you do this, however, you may have to manually adjust some preferences every time you visit a site and some services and functionalities may not work.

Strictly Necessary
Cookies
Always Active

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance
Cookies

These cookies are used to collect information about how visitors use our website. We use the information to compile reports and to help us improve the website. The cookies collect information in an anonymous form, including the number of visitors to the website, where visitors have come to the website from and the pages they visited.

Google Analytics

This website uses Google Analytics, a website analytics service provided by Google, Inc. (“Google”). Google Analytics uses cookies and the information generated by the cookie is usually transmitted to a Google server in the USA and stored there.

You can prevent Google’s collection of the data generated by the cookie and related use of the website, including your IP address, as well as the processing of such data by Google by downloading and installing the browser plug-in available under the following link: http://tolls.google.com/dlpage/gaoptout.

Targeting
Cookies

These Cookies are used by advertising companies to inform and serve personalized ads more relevant to your interests. These Cookies also may facilitate sharing information with social networks or recording your interactions with particular ads.

We currently do not use any cookies in this category